CRISPR Therapeutics AG
CRSP- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001674416
In the last 90 days, CRISPR Therapeutics AG insiders filed 0 open-market purchases and 2 sales; 525 institutions reported holding it in 13F filings for Q2 2026, worth $4.16B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in CRISPR Therapeutics AG as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 420
- +40 vs. Q1 2023
- Shares held
- 54.8M
- −1.43M (−2.5%) vs. Q1 2023
- Total value
- $3.07B
- +$533.0M (+21.0%) vs. Q1 2023
- New holders
- 66
- 95 more added
- Sold out
- 26
- 137 more reduced
3 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 525 | $4.16B |
| Q1 2026 | 494 | $3.67B |
| Q4 2025 | 482 | $4.01B |
| Q3 2025 | 442 | $4.68B |
| Q2 2025 | 435 | $3.52B |
| Q1 2025 | 398 | $2.20B |
| Q4 2024 | 406 | $2.54B |
| Q3 2024 | 417 | $2.81B |
| Q2 2024 | 450 | $3.22B |
| Q1 2024 | 483 | $4.10B |
| Q4 2023 | 472 | $3.48B |
| Q3 2023 | 410 | $2.50B |
| Q2 2023 | 420 | $3.07B |
| Q1 2023 | 383 | $2.54B |
| Q4 2022 | 399 | $2.26B |
| Q3 2022 | 436 | $3.70B |
| Q2 2022 | 437 | $3.35B |
| Q1 2022 | 446 | $3.10B |
| Q4 2021 | 448 | $3.25B |
| Q3 2021 | 477 | $4.53B |
| Q2 2021 | 501 | $6.57B |
| Q1 2021 | 446 | $5.20B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding CRISPR Therapeutics AG; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 551,395 | $31.0M | 0.00% | −31,269−5.4% | Reduced |
| Norges Bank | 577,033 | $32.4M | 0.01% | −52,619−8.4% | Reduced |
| Charles Schwab Investment Management Inc | 646,711 | $36.3M | 0.01% | +5,934+0.9% | Added |
| Dimensional Fund Advisors LP | 711,271 | $39.9M | 0.01% | −48,464−6.4% | Reduced |
| Bank of America Corp | 754,557 | $42.4M | 0.01% | +236,851+45.8% | Added |
| Geode Capital Management, LLC | 834,607 | $46.9M | 0.01% | +24,623+3.0% | Added |
| Price T Rowe Associates Inc | 882,375 | $49.5M | 0.01% | −220,346−20.0% | Reduced |
| Bellevue Group AG | 899,300 | $50.5M | 0.72% | −500−0.1% | Reduced |
| Credit Suisse AG | 921,656 | $51.7M | 0.05% | +74,383+8.8% | Added |
| Loomis Sayles & Co L P | 1,147,929 | $64.4M | 0.10% | −8,881−0.8% | Reduced |
| Vanguard Group Inc | 1,531,090 | $86.0M | 0.00% | +46,521+3.1% | Added |
| NEA Management Company, LLC | 1,587,854 | $89.1M | 6.80% | 00.0% | Unchanged |
| State Street Corp | 1,632,473 | $91.6M | 0.00% | −353,714−17.8% | Reduced |
| FMR LLC | 2,091,173 | $117.4M | 0.01% | −47,883−2.2% | Reduced |
| BlackRock Inc. | 2,718,575 | $152.6M | 0.00% | −80,006−2.9% | Reduced |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198.3M | 2.09% | −438,782−11.0% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 3,533,357 | $198.4M | 0.15% | −439,823−11.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 3,646,582 | $204.7M | 0.14% | −17,789−0.5% | Reduced |
| Capital International Investors | 6,069,723 | $340.8M | 0.08% | +46,085+0.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 7,338,447 | $412.0M | 2.73% | −651,741−8.2% | Reduced |
| Lombard Odier Asset Management (Switzerland) SA | 0 | $0 | 0.00% | −54,786−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −34,200−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −26,597−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −23,442−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −22,185−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,736−100.0% | Sold out |
| Nia Impact Advisors, LLC | 0 | $0 | 0.00% | −5,620−100.0% | Sold out |
| Ionic Capital Management LLC | 0 | $0 | 0.00% | −4,721−100.0% | Sold out |
| Lauer Wealth, LLC | 0 | $0 | 0.00% | −4,030−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,241−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −623−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Old North State Trust, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Coston, McIsaac & Partners | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| New Millennium Group LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Robbins Farley LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Asset Management Corp | – | – | – | – | Not filed |
| Ahrens Investment Partners LLC | – | – | – | – | Not filed |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |